Different types of T-effector cells orchestrate mucosal inflammation in chronic sinus disease

Journal of Allergy and Clinical Immunology

Volumn 122, Issue 5, 2008, Pages 961-968

  Zhang, Nan ^a,b   Van Zele, Thibaut ^a   Perez Novo, Claudina ^a   Van Bruaene, Nicholas ^a   Holtappels, Gabriele ^a   DeRuyck, Natalie ^a   Van Cauwenberge, Paul ^a   Bachert, Claus ^a  

^a GHENT UNIVERSITY HOSPITAL   (Belgium)

^b Zhongshan City Peoples Hospital   (China)

Author keywords

Airway inflammation; chronic rhinosinusitis; eosinophils; Foxp3; IL 17A; nasal polyps; regulatory T cells; TH17; TH2; TGF 1

Indexed keywords

IMMUNOGLOBULIN E; INTERLEUKIN 2 RECEPTOR; TRANSCRIPTION FACTOR FOXP3; TRANSFORMING GROWTH FACTOR BETA1;

ADULT; ARTICLE; ASTHMA; CHRONIC SINUSITIS; CLINICAL FEATURE; COMORBIDITY; COMPUTER ASSISTED TOMOGRAPHY; CONTROLLED STUDY; FEMALE; GRANULOCYTE; HUMAN; HUMAN TISSUE; MAJOR CLINICAL STUDY; MALE; MUCOSA INFLAMMATION; NOSE CONGESTION; NOSE POLYP; PHENOTYPE; PRIORITY JOURNAL; PROTEIN EXPRESSION; RHINORRHEA; RHINOSINUSITIS; T LYMPHOCYTE; T LYMPHOCYTE ACTIVATION;

ASIAN CONTINENTAL ANCESTRY GROUP; ASTHMA; BELGIUM; CHINA; CHRONIC DISEASE; COMORBIDITY; EUROPEAN CONTINENTAL ANCESTRY GROUP; HUMANS; NASAL MUCOSA; NASAL POLYPS; RHINITIS; SINUSITIS; T-LYMPHOCYTE SUBSETS; T-LYMPHOCYTES, REGULATORY;

EID: 55549099882     PISSN: 00916749     EISSN: None     Source Type: Journal    
DOI: 10.1016/j.jaci.2008.07.008     Document Type: Article

References (35)

1. Fokkens W., Lund V., Bachert C., Clement P., Helllings P., Holmstrom M., et al. EAACI position paper on rhinosinusitis and nasal polyps executive summary. Allergy 60 (2005) 583-601
2. Meltzer E.O., Hamilos D.L., Hadley J.A., Lanza D.C., Marple B.F., Nicklas R.A., et al. Rhinosinusitis: establishing definitions for clinical research and patient care. J Allergy Clin Immunol 114 (2004) 155-212
3. Bateman N.D., Shahi A., Feeley K.M., and Woolford T.J. Activated eosinophils in nasal polyps: a comparison of asthmatic and non-asthmatic patients. Clin Otolaryngol 30 (2005) 221-225
4. Ediger D., Sin B.A., Heper A., Anadolu Y., and Misirligil Z. Airway inflammation in nasal polyposis: immunopathological aspects of relation to asthma. Clin Exp Allergy 35 (2005) 319-326
5. Van Zele T., Claeys S., Gevaert P., Van Maele G., Holtappels G., Van Cauwenberge P., et al. Differentiation of chronic sinus diseases by measurement of inflammatory mediators. Allergy 61 (2006) 1280-1289
6. Bachert C., Wagenmann M., Hauser U., and Rudack C. IL-5 synthesis is upregulated in human nasal polyp tissue. J Allergy Clin Immunol 99 (1997) 837-842
7. Simon H.U., Yousefi S., Schranz C., Schapowal A., Bachert C., and Blaser K. Direct demonstration of delayed eosinophil apoptosis as a mechanism causing tissue eosinophilia. J Immunol 158 (1997) 3902-3908
8. Bachert C., Gevaert P., Holtappels G., Cuvelier C., and van Cauwenberge P. Nasal polyposis: from cytokines to growth. Am J Rhinol 14 (2000) 279-290
9. Beck L.A., Stellato C., Beall L.D., Schall T.J., Leopold D., Bickel C.A., et al. Detection of the chemokine RANTES and endothelial adhesion molecules in nasal polyps. J Allergy Clin Immunol 98 (1996) 766-780
10. Bachert C., Gevaert P., Holtappels G., Johansson S.G., and van Cauwenberge P. Total and specific IgE in nasal polyps is related to local eosinophilic inflammation. J Allergy Clin Immunol 107 (2001) 607-614
11. Zhang N., Gevaert P., van Zele T., Perez-Novo C., Patou J., Holtappels G., et al. An update on the impact of Staphylococcus aureus enterotoxins in chronic sinusitis with nasal polyposis. Rhinology 43 (2005) 162-168
12. Zhang N., Holtappels G., Claeys C., Huang G., van Cauwenberge P., and Bachert C. Pattern of inflammation and impact of Staphylococcus aureus enterotoxins in nasal polyps from southern China. Am J Rhinol 20 (2006) 445-450
13. Jareoncharsri B.C., and Muangsomboon S. Clinical and histopathological classification of nasal polyps in Thais. Siriraj Hospital Gazette 54 (2002) 9
14. Van Bruaene N., Pérez-Novo C.A., Basinski T.M., Van Zele T., Holtappels G., De Ruyck N., et al. T-cell regulation in chronic paranasal sinus disease. J Allergy Clin Immunol 121 (2008) 1435-1441
15. Lund V.J., and Kennedy D.W. Staging for rhinosinusitis. Otolaryngol Head Neck Surg 117 suppl (1997) S35-S40
16. Perez-Novo C.A., Claeys C., Speleman F., Van Cauwenberge P., Bachert C., and Vandesompele J. Impact of RNA quality on reference gene expression stability. Biotechniques 39 (2005) 52 4, 6
17. Szabo S.J., Kim S.T., Costa G.L., Zhang X., Fathman C.G., and Glimcher L.H. A novel transcription factor, T-bet, directs Th1 lineage commitment. Cell 100 (2000) 655-669
18. Zhang D.H., Yang L., Cohn L., Parkyn L., Homer R., Ray P., et al. Inhibition of allergic inflammation in a murine model of asthma by expression of a dominant-negative mutant of GATA-3. Immunity 11 (1999) 473-482
19. Nakamura Y., Ghaffar O., Olivenstein R., Taha R.A., Soussi-Gounni A., Zhang D.H., et al. Gene expression of the GATA-3 transcription factor is increased in atopic asthma. J Allergy Clin Immunol 103 (1999) 215-222
20. Erpenbeck V.J., Hohlfeld J.M., Discher M., Krentel H., Hagenberg A., Braun A., et al. Increased messenger RNA expression of c-maf and GATA-3 after segmental allergen challenge in allergic asthmatics. Chest 123 suppl (2003) 370S-371S
21. Harrington L.E., Hatton R.D., Mangan P.R., Turner H., Murphy T.L., Murphy K.M., et al. Interleukin 17-producing CD4+ effector T cells develop via a lineage distinct from the T helper type 1 and 2 lineages. Nat Immunol 6 (2005) 1123-1132
22. Park H., Li Z., Yang X.O., Chang S.H., Nurieva R., Wang Y.H., et al. A distinct lineage of CD4 T cells regulates tissue inflammation by producing interleukin 17. Nat Immunol 6 (2005) 1133-1141
23. Ivanov II, McKenzie B.S., Zhou L., Tadokoro C.E., Lepelley A., Lafaille J.J., et al. The Orphan Nuclear Receptor RORγt directs the differentiation program of proinflammatory IL-17+ T helper cells. Cell 126 (2006) 1121-1133
24. Yao Z., Fanslow W.C., Seldin M.F., Rousseau A.M., Painter S.L., Comeau M.R., et al. Herpesvirus Saimiri encodes a new cytokine, IL-17, which binds to a novel cytokine receptor. Immunity 3 (1995) 811-821
25. Fossiez F., Djossou O., Chomarat P., Flores-Romo L., Ait-Yahia S., Maat C., et al. T cell interleukin-17 induces stromal cells to produce proinflammatory and hematopoietic cytokines. J Exp Med 183 (1996) 2593-2603
26. Fontenot J.D., Gavin M.A., and Rudensky A.Y. Foxp3 programs the development and function of CD4+CD25+ regulatory T cells. Nat Immunol 4 (2003) 330-336
27. Fontenot J.D., Rasmussen J.P., Gavin M.A., and Rudensky A.Y. A function for interleukin 2 in Foxp3-expressing regulatory T cells. Nat Immunol 6 (2005) 1142-1151
28. Coutinho A., Caramalho I., Seixas E., and Demengeot J. Thymic commitment of regulatory T cells is a pathway of TCR-dependent selection that isolates repertoires undergoing positive or negative selection. Curr Top Microbiol Immunol 293 (2005) 43-71
29. Walker M.R., Kasprowicz D.J., Gersuk V.H., Benard A., Van Landeghen M., Buckner J.H., et al. Induction of FoxP3 and acquisition of T regulatory activity by stimulated human CD4+CD25- T cells. J Clin Invest 112 (2003) 1437-1443
30. Walker M.R., Carson B.D., Nepom G.T., Ziegler S.F., and Buckner J.H. De novo generation of antigen-specific CD4+CD25+ regulatory T cells from human CD4+CD25- cells. Proc Natl Acad Sci U S A 102 (2005) 4103-4108
31. Chen W., Jin W., Hardegen N., Lei K.J., Li L., Marinos N., et al. Conversion of peripheral CD4+CD25- naive T cells to CD4+CD25+ regulatory T cells by TGF-beta induction of transcription factor Foxp3. J Exp Med 198 (2003) 1875-1886
32. Umetsu D.T., and DeKruyff R.H. The regulation of allergy and asthma. Immunol Rev 212 (2006) 238-255
33. Mantel P.Y., Kuipers H., Boyman O., Rhyner C., Ouaked N., Ruckert B., et al. GATA3-driven Th2 responses inhibit TGF-beta1-induced FOXP3 expression and the formation of regulatory T cells. PLoS Biol 5 (2007) e329
34. Dorman S.C., Sehmi R., Gauvreau G.M., Watson R.M., Foley R., Jones G.L., et al. Kinetics of bone marrow eosinophilopoiesis and associated cytokines after allergen inhalation. Am J Respir Crit Care Med 169 (2004) 565-572
35. Gevaert P., Lang-Loidolt D., Lackner A., Stammberger H., Staudinger H., Van Zele T., et al. Nasal IL-5 levels determine the response to anti-IL-5 treatment in patients with nasal polyps. J Allergy Clin Immunol 118 (2006) 1133-1141